Creative Bioarray Launches In Vitro Metabolism Assay Kits to Streamline Drug Development

Creative Bioarray's new in vitro metabolism assay kits leverage CYP450 and UGT enzyme systems to enhance drug testing accuracy and efficiency, addressing critical early-stage drug development needs.

Bay Area Metrowire Staff
Business
Creative Bioarray Launches In Vitro Metabolism Assay Kits to Streamline Drug Development

Creative Bioarray, a provider of life science research reagents and services, has announced the launch of a new suite of personalized, high-efficiency in vitro metabolic assay kits and reagents. These kits are designed to support researchers and pharmaceutical companies in studying drug metabolism with greater precision and flexibility, addressing a crucial phase in drug development.

The newly introduced kits are built upon widely used cytochrome P450 (CYP450) and UDP-glucuronyl transferase (UGT) enzyme systems. By utilizing these biochemical pathways, researchers can gain insights into Phase I and Phase II metabolic processes, which are essential for making informed decisions in drug development. The kits enable detailed assessments of compound metabolic stability, drug interactions, and identification of metabolic pathways.

Key features of the in vitro metabolism analysis kits include comprehensive support for drug testing, allowing researchers to conduct detailed evaluations of interactions between various compounds and metabolic enzymes. The kits offer customizable protocols, enabling users to tailor experiments to specific needs, thereby improving data relevance and reliability. According to Hannah Cole, marketing director of Creative Bioarray, these scalable solutions are designed with versatility in mind, meeting diverse throughput requirements suitable for both small laboratories and large-scale industrial applications.

Drug metabolism is a complex process involving both synthetic and non-synthetic reactions. Creative Bioarray's kits streamline drug testing by providing necessary reagents and protocols, effectively addressing mechanisms such as oxidation, reduction, hydrolysis, conjugation, and formation of more readily excreted polar metabolites. Current kits focus on Phase I and II metabolic reactions, which are critical for understanding drug behavior.

By using these products, researchers can significantly accelerate drug development, ensuring their leading position in the competitive biopharmaceutical field. Creative Bioarray also offers a range of specialized services related to in vitro metabolism, including custom assays for drug interactions and metabolite identification, expanding support beyond test kits. This integration ensures comprehensive support throughout the entire drug development process.

Creative Bioarray's commitment to innovation and quality continues to empower scientists worldwide to explore effective treatments. For more information about the in vitro metabolism assay kits, visit Creative Bioarray.

Blockchain Registration

QR Code for Blockchain Registration